Robert Malcolm to Cocaine-Related Disorders
This is a "connection" page, showing publications Robert Malcolm has written about Cocaine-Related Disorders.
Connection Strength
3.068
-
A double-blind placebo-controlled trial of N-acetylcysteine in the treatment of cocaine dependence. Am J Addict. 2013 Sep-Oct; 22(5):443-52.
Score: 0.295
-
The Obsessive Compulsive Cocaine Scale: assessment of factor structure, reliability, and validity. Addict Behav. 2011 Dec; 36(12):1223-7.
Score: 0.261
-
Disulfiram: an old therapeutic with new applications. CNS Neurol Disord Drug Targets. 2010 Mar; 9(1):5-12.
Score: 0.236
-
Measures of cognitive functioning as predictors of treatment outcome for cocaine dependence. J Subst Abuse Treat. 2009 Dec; 37(4):328-34.
Score: 0.223
-
The safety of disulfiram for the treatment of alcohol and cocaine dependence in randomized clinical trials: guidance for clinical practice. Expert Opin Drug Saf. 2008 Jul; 7(4):459-72.
Score: 0.211
-
Is cocaine desire reduced by N-acetylcysteine? Am J Psychiatry. 2007 Jul; 164(7):1115-7.
Score: 0.197
-
An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: a pilot study. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Mar 30; 31(2):389-94.
Score: 0.188
-
Modafinil and cocaine interactions. Am J Drug Alcohol Abuse. 2006; 32(4):577-87.
Score: 0.177
-
A controlled trial of amlodipine for cocaine dependence: a negative report. J Subst Abuse Treat. 2005 Mar; 28(2):197-204.
Score: 0.167
-
Amlodipine reduces blood pressure and headache frequency in cocaine-dependent outpatients. J Psychoactive Drugs. 2002 Oct-Dec; 34(4):415-9.
Score: 0.141
-
Divalproex loading in the treatment of cocaine dependence. J Psychoactive Drugs. 2001 Jul-Sep; 33(3):283-7.
Score: 0.130
-
Gabapentin in the treatment of cocaine dependence: a case series. J Clin Psychiatry. 2001 Jan; 62(1):19-23.
Score: 0.125
-
Adverse outcomes in a controlled trial of pergolide for cocaine dependence. J Addict Dis. 2001; 20(1):81-92.
Score: 0.125
-
A double-blind, placebo-controlled outpatient trial of pergolide for cocaine dependence. Drug Alcohol Depend. 2000 Aug 01; 60(2):161-8.
Score: 0.122
-
Cardiac and mood-related changes during short-term abstinence from crack cocaine: the identification of possible withdrawal phenomena. Am J Drug Alcohol Abuse. 1999 Nov; 25(4):629-37.
Score: 0.116
-
Amlodipine treatment of cocaine dependence. J Psychoactive Drugs. 1999 Apr-Jun; 31(2):117-20.
Score: 0.111
-
Characteristics of cocaine- and marijuana-dependent subjects presenting for medication treatment trials. Addict Behav. 2007 Jul; 32(7):1433-40.
Score: 0.047
-
Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals. Am J Addict. 2006 Jan-Feb; 15(1):105-10.
Score: 0.044
-
Modafinil influences the pharmacokinetics of intravenous cocaine in healthy cocaine-dependent volunteers. Clin Pharmacokinet. 2005; 44(7):753-65.
Score: 0.041
-
Gabapentin abuse in inmates with prior history of cocaine dependence. Am J Addict. 2004 May-Jun; 13(3):321-3.
Score: 0.039
-
Carbamazepine in the treatment of cocaine dependence: subtyping by affective disorder. Exp Clin Psychopharmacol. 2002 Aug; 10(3):276-85.
Score: 0.035
-
The role of weight control as a motivation for cocaine abuse. Addict Behav. 1998 Mar-Apr; 23(2):201-7.
Score: 0.026
-
Chiral analysis of d- and l-modafinil in human serum: application to human pharmacokinetic studies. Ther Drug Monit. 2003 Apr; 25(2):197-202.
Score: 0.009